NCT01316926 - Paxil CR Bioequivalence Study Brazil | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 9, 2009

Primary Completion Date

October 5, 2009

Study Completion Date

October 5, 2009

Conditions

Depressive Disorder

Interventions

DRUG

Test formulation

Paroxetine Hydrochloride 25 miligrams (mg) tablet with controlled release (Paxil CR) manufactured by GlaxoSmithKline Inc. - Mississauga - Canada (test formulation)

DRUG

Reference formulation

Paroxetine Hydrochloride 25 mg tablets with controlled release (Paxil CR) manufactured by SmithKline Beecham (Cork) Limited - Cidra - Puerto Rico (reference formulation)

Trial Locations (1)

30110-014

GSK Investigational Site, Belo Horizonte